Last updated on November 2018

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis


Brief description of study

This is a study to compare the efficacy of bimekizumab versus secukinumab in subjects with moderate to severe chronic plaque psoriasis (PSO).

Clinical Study Identifier: NCT03536884

Contact Investigators or Research Sites near you

Start Over

UCB Cares

Ps0015 661
Peterborough, Canada
  Connect »